Published in Chest on April 01, 1995
Asthma outcomes: pulmonary physiology. J Allergy Clin Immunol (2012) 1.02
Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax (2003) 4.53
Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J (2002) 3.66
Regular vs as-needed inhaled salbutamol in asthma control. Lancet (1994) 3.59
Bronchodilator responsiveness in patients with COPD. Eur Respir J (2008) 3.13
What is new since the last (1999) Canadian Asthma Consensus Guidelines? Can Respir J (2001) 2.65
Medical personnel's knowledge of and ability to use inhaling devices. Metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers. Chest (1994) 2.15
Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD. Eur Respir J (2007) 2.03
Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial. Eur Respir J (2010) 2.01
Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. Am J Respir Crit Care Med (1997) 1.86
Pharmacist knowledge and ability to use inhaled medication delivery systems. Chest (1993) 1.80
Reality-based medicine. Chest (2000) 1.78
Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response. Am J Respir Crit Care Med (1997) 1.71
Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation. Am J Respir Crit Care Med (2001) 1.69
Physiologic and nonphysiologic determinants of aerobic fitness in mild to moderate asthma. Am Rev Respir Dis (1992) 1.66
Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room. Am J Med (1987) 1.65
Hemodynamic effects of inhaled ipratropium bromide, alone and combined with an inhaled beta 2-agonist. Am Rev Respir Dis (1985) 1.59
The accuracy and response characteristics of a simplified ear oximeter. Chest (1983) 1.56
Long-term efficacy of tiotropium in relation to smoking status in the UPLIFT trial. Eur Respir J (2009) 1.52
Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia. Neurosci Lett (1997) 1.49
Bronchiolitis obliterans after lung transplantation: a review. Chest (1998) 1.45
Adverse effects of inhaled corticosteroids. Am J Med (1995) 1.39
Aerosol therapy in Canada: what are the standards? CMAJ (1993) 1.38
Trends in pharmacotherapy for chronic airflow limitation in Argentina: 1983-1990. Medicina (B Aires) (1994) 1.38
Exhaled nitric oxide after beta2-agonist inhalation and spirometry in asthma. Am J Respir Crit Care Med (1999) 1.28
Range of accuracy of two wavelength oximetry. Chest (1986) 1.22
Psychological functioning and quality of life in lung transplant candidates and recipients. Chest (2000) 1.20
Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes. Int J Chron Obstruct Pulmon Dis (2009) 1.19
Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPD. Pulm Pharmacol Ther (2005) 1.19
One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium. Pulm Pharmacol Ther (2004) 1.17
Physician perceptions and management of COPD. Chest (1993) 1.17
Maximal inspiratory and expiratory pressures in adolescents. Normal values. Chest (1984) 1.17
Tolerance to bronchodilating effects of salmeterol in COPD. Respir Med (2003) 1.15
The six-minute walk test: a guide to assessment for lung transplantation. J Heart Lung Transplant (1997) 1.14
Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol (1995) 1.13
Comparison of hallway and treadmill six-minute walk tests. Am J Respir Crit Care Med (1999) 1.11
Changes in inspiratory muscle electrical activity and upper airway resistance during periodic breathing induced by hypoxia during sleep. Am Rev Respir Dis (1987) 1.09
Extrathoracic angiomyolipomas in lymphangioleiomyomatosis. Eur Respir J (1996) 1.08
The patient level cost of asthma in adults in south central Ontario. Pharmacy Medication Monitoring Program Advisory Board. Can Respir J (1999) 1.08
Exhaled nitric oxide as a noninvasive assessment of chronic cough. Am J Respir Crit Care Med (1999) 1.07
Aspergillus infection in single and double lung transplant recipients. Transplantation (1996) 1.06
Corticosteroid therapy for patients with acute exacerbations of chronic obstructive pulmonary disease: a systematic review. Arch Intern Med (2002) 1.06
Prevalence of inhaled corticosteroid use among patients with chronic obstructive pulmonary disease: a survey. Ann Pharmacother (1997) 1.05
COPD in young patients: a pre-specified analysis of the four-year trial of tiotropium (UPLIFT). Respir Med (2010) 1.05
Factors associated with emergency department dependence of patients with asthma. Chest (1997) 1.04
Lymphocytic airway infiltration as a precursor to fibrous obliteration in a rat model of bronchiolitis obliterans. Transplantation (1997) 1.04
Effective delivery of particles with the HandiHaler dry powder inhalation system over a range of chronic obstructive pulmonary disease severity. J Aerosol Med (2001) 1.03
Improvements with tiotropium in COPD patients with concomitant asthma. Respir Med (2007) 1.01
Pulmonary function in adolescents with mild idiopathic scoliosis. Thorax (1984) 1.01
A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma. Am Rev Respir Dis (1991) 1.00
Exhaled nitric oxide and bronchial reactivity during and after inhaled beclomethasone in mild asthma. J Asthma (1998) 0.99
The accuracy of a handheld portable spirometer. Chest (1996) 0.98
Quality and reproducibility of spirometry in COPD patients in a randomized trial (UPLIFT®). Respir Med (2013) 0.96
Hemodynamic effects of an inhaled beta-2 agonist. Clin Pharmacol Ther (1984) 0.96
Respiratory rate during acute asthma. Chest (1990) 0.95
Diagnosis and treatment considerations for women with COPD. Int J Clin Pract (2009) 0.95
Reliability of ventilatory parameters during cycle ergometry in multicentre trials in COPD. Eur Respir J (2009) 0.94
Assessment of patient performance of the HandiHaler compared with the metered dose inhaler four weeks after instruction. Respir Med (2003) 0.93
Patient handling of a dry-powder inhaler in clinical practice. Chest (2001) 0.93
Exhaled nitric oxide in chronic obstructive pulmonary disease: relationship to pulmonary function. Eur Respir J (2001) 0.93
Variability in performance of timed walk tests in pulmonary rehabilitation programs. Chest (2000) 0.93
Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline. Can Respir J (2012) 0.92
The impact of a nationally coordinated pharmacy-based asthma education intervention. Can Respir J (2001) 0.92
Assessment of airway tone in asthma. Comparison between double lung transplant patients and healthy subjects. Am Rev Respir Dis (1993) 0.92
[Attitudes toward the diagnosis of chronic obstructive pulmonary disease in primary care]. Arch Bronconeumol (2006) 0.91
Indirect effects of heavy metals on parasites may cause shifts in snail species compositions. Arch Environ Contam Toxicol (2002) 0.91
Leukotriene-receptor antagonists. Role in asthma management. Can Fam Physician (2000) 0.91
Cardiovascular safety of high doses of inhaled fenoterol and albuterol in acute severe asthma. Chest (1996) 0.91
Effect of inhaled furosemide in acute asthma. J Asthma (1998) 0.90
Asthma: 2. Trends in pharmacologic therapy. CMAJ (1987) 0.90
Validation of the Doser, a new device for monitoring metered-dose inhaler use. J Allergy Clin Immunol (1998) 0.90
Pleural complications in lung transplant recipients. J Thorac Cardiovasc Surg (1995) 0.90
Induced sputum: comparison of postinfectious cough with allergic asthma in children. J Allergy Clin Immunol (2000) 0.90
Alpha1-antitrypsin deficiency: a position statement of the Canadian Thoracic Society. Can Respir J (2001) 0.90
Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group. J Allergy Clin Immunol (1999) 0.88
Prior diagnosis and treatment of patients with normal results of methacholine challenge and unexplained respiratory symptoms. Chest (1996) 0.88
Exhaled nitric oxide in human lung transplantation. A noninvasive marker of acute rejection. Am J Respir Crit Care Med (1998) 0.88
Emergency room care of asthmatics: a comparison between Auckland and Toronto. Ann Allergy (1991) 0.88
Exhaled nitric oxide and hydrogen peroxide in patients with chronic obstructive pulmonary disease: effects of inhaled beclomethasone. Am J Respir Crit Care Med (2001) 0.88
Bronchiolitis obliterans organizing pneumonia (BOOP) in lung transplant recipients. Chest (1996) 0.88
The placebo effect in asthma drug therapy trials: a meta-analysis. J Asthma (2000) 0.87
Ventilatory patterns during hypoxia, hypercapnia, and exercise in adolescents with mild scoliosis. Pediatrics (1986) 0.87
Causes of death in lung transplant recipients. J Heart Lung Transplant (1995) 0.87
Asthma education. Chest (1994) 0.87
Return to work after lung transplantation. J Heart Lung Transplant (1998) 0.86
Hepatitis C virus infection and lung transplantation: a survey of practices. J Heart Lung Transplant (1999) 0.86
Quality of life in female lung transplant candidates and recipients. Chest (1997) 0.85
Assessment of an ambulatory care asthma program. J Asthma (1994) 0.85
The effect of structured versus conventional inhaler education in medical housestaff. J Asthma (1996) 0.84
Status of lung transplant recipients surviving beyond five years. J Heart Lung Transplant (1997) 0.84
Effectiveness and safety of salmeterol in nonspecialist practice settings. Chest (2001) 0.84